topic_keywords,"Excited (Positive, High arousal)",Negative (Low/Med arousal),Neutral,Positive (Low/Mid arousal)
Outlier,7,5,7,5
autologous stem,2,16,39,12
clinical milestones,2,16,39,12
late line,2,16,39,12
later line,2,16,39,12
low risk,2,16,39,12
multiple myeloma,2,16,39,12
net sales,2,5,20,0
patient population,2,16,39,12
refractory myeloma,2,16,39,12
regulatory approval,2,16,39,12
relevant dose,2,16,39,12
sequential growth,2,5,20,0
strong sales,2,5,20,0
